Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Otitis Externa D010032 8 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Peritonitis D010538 38 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Vaginitis D014627 6 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Dermatomycoses D003881 17 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Johnson EM et al. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. 1998 Antimicrob. Agents Chemother. pmid:9624486
Cosgrove RF and Fairbrother JE Bioassay method for polyene antibiotics based on the measurement of rubidium efflux from rubidium-loaded yeast cells. 1977 Antimicrob. Agents Chemother. pmid:319752
Mehta RT et al. Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. 1987 Antimicrob. Agents Chemother. pmid:3439798
Mehta RT et al. Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. 1987 Antimicrob. Agents Chemother. pmid:3439799
Ostrosky-Zeichner L et al. Differential antifungal activity of isomeric forms of nystatin. 2001 Antimicrob. Agents Chemother. pmid:11557469
Alonso MA et al. Compounds affecting membranes that inhibit protein synthesis in yeast. 1979 Antimicrob. Agents Chemother. pmid:394675
te Welscher YM et al. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. 2010 Antimicrob. Agents Chemother. pmid:20385867
Hahn DM et al. Infection in acute leukemia patients receiving oral nonabsorable antibiotics. 1978 Antimicrob. Agents Chemother. pmid:98107
Chen WC et al. Dissociation between ion permeability and the lethal action of polyene antibiotics on Candida albicans. 1978 Antimicrob. Agents Chemother. pmid:354520
González GM et al. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. 2002 Antimicrob. Agents Chemother. pmid:11959606
Gunderson SM et al. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect. 2000 Antimicrob. Agents Chemother. pmid:10991881
Kasbekar DP et al. Self-induced nystatin resistance in Dictyostelium discoideum. 1985 Antimicrob. Agents Chemother. pmid:4026273
Boyce ST et al. Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. 1995 Antimicrob. Agents Chemother. pmid:7574524
Venables P and Russell AD Nystatin-induced changes in Saccharomyces cerevisiae. 1975 Antimicrob. Agents Chemother. pmid:1094947
Tevyashova AN et al. Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. 2013 Antimicrob. Agents Chemother. pmid:23716057
Groll AH et al. Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits. 2000 Antimicrob. Agents Chemother. pmid:10722496
Serfling A et al. Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. 2007 Antimicrob. Agents Chemother. pmid:17620378
Offner F et al. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. 2004 Antimicrob. Agents Chemother. pmid:15561860
Flattery AM et al. New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents. 1996 Antimicrob. Agents Chemother. pmid:8807048
Iannitelli RC and Ikawa M Effect of fatty acids on action of polyene antibiotics. 1980 Antimicrob. Agents Chemother. pmid:6994641
Wallace TL et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. 1997 Antimicrob. Agents Chemother. pmid:9333054
Akiyama S et al. Classification of polyene antibiotics according to their synergistic effect in combination with bleomycin A2 or fusidic acid. 1980 Antimicrob. Agents Chemother. pmid:6160808
Bruheim P et al. Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC. 2004 Antimicrob. Agents Chemother. pmid:15504830
Whitbeck E et al. Superiority of amphotericin over nystatin in Thayer-Martin medium. 1975 Antimicrob. Agents Chemother. pmid:807158
Oakley KL et al. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. 1999 Antimicrob. Agents Chemother. pmid:10223948
Cassidy SM et al. Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins. 1998 Antimicrob. Agents Chemother. pmid:9687378
Aszalos A Differential potentiation by nystatin of the effect of antibiotics on yeast and mammalian cells. 1975 Antimicrob. Agents Chemother. pmid:1171651
Kobayashi GS and Medoff G Antifungal agents: recent developments. 1977 Annu. Rev. Microbiol. pmid:334040
Gonzalez-Lavin L and O'Connell TX Mitral valve replacement with viable aortic homograft valves. 1973 Ann. Thorac. Surg. pmid:4708287
Brooks JR et al. Bacteriology of the stomach immediately following vagotomy: the growth of Candida albicans. 1974 Ann. Surg. pmid:4599845
Mowat AG et al. Articular scanning and external counting in experimental synovitis in the guinea-pig. 1971 Ann. Rheum. Dis. pmid:5569440
Mowat AG et al. Effect of iron dextran, gold thiosulphate, and hydrocortisone acetate on experimental synovitis in the guinea pig. 1971 Ann. Rheum. Dis. pmid:5569441
WEISSKOPF A MUCORMYCOSIS--A RHINOLOGIC DISEASE. 1964 Ann. Otol. Rhinol. Laryngol. pmid:14128702
Yonkers AJ Candidiasis of the larynx. 1973 Nov-Dec Ann. Otol. Rhinol. Laryngol. pmid:4586607
WITHERS BT Combining antibiotic with antigen therapy in cases in T.O.E. (yeast and fungus) allergy. 1960 Ann. Otol. Rhinol. Laryngol. pmid:13845442
Nickerson WJ Chemical composition of cell walls and membranes of yeasts. 1974 Ann. N. Y. Acad. Sci. pmid:4604209
HAZEN EL and BROWN R Nystatin. 1960 Ann. N. Y. Acad. Sci. pmid:13712559
Kracke GR and Drake RK Halothane, enflurane, and isoflurane inhibit sodium/proton exchange in mammalian erythrocytes. 1991 Ann. N. Y. Acad. Sci. pmid:1647742
Holz RW The effects of the polyene antibiotics nystatin and amphotericin B on thin lipid membranes. 1974 Ann. N. Y. Acad. Sci. pmid:4528030
Andreoli TE The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes. 1974 Ann. N. Y. Acad. Sci. pmid:4528067
Marley PD et al. How does histamine evoke catecholamine secretion from bovine chromaffin cells? 2002 Ann. N. Y. Acad. Sci. pmid:12438107
Ingelfinger JA Routine testing for chlamydial cervical infections. 1988 Ann. Intern. Med. pmid:3337502
Rapi G and Cocchi P Antifungal agents. 1979 Ann. Intern. Med. pmid:420451
Stinson EB et al. Infectious complications after cardiac transplantation in man. 1971 Ann. Intern. Med. pmid:4923804
Schimpff SC et al. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. 1975 Ann. Intern. Med. pmid:1054222
HARRELL ER and THOMPSON GR Systemic candidiasis (moniliasis) complicating treatment of bacterial endocarditis, with review of literature and report of apparent cure of one case with parenteral mycostatin. 1958 Ann. Intern. Med. pmid:13545747
SAREWITZ AB Treatment of genitourinary moniliasis with orally administered nystatin. 1955 Ann. Intern. Med. pmid:14377252
Ouédraogo M et al. Free radical scavenging capacity, anticandicidal effect of bioactive compounds from Sida cordifolia L., in combination with nystatin and clotrimazole and their effect on specific immune response in rats. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:23268761
Shinde RB et al. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:23035934
Serhan G et al. The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides. 2014 Ann. Clin. Microbiol. Antimicrob. pmid:24884795